RxDoctor Payments Data

Lana Chahine

Neurology · Pittsburgh, PANPI 1962672238

Payments from drug & device makers

What this record shows

That places this record below the midpoint for neurology clinicians in PA, where the typical reported total is $778.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$633,301in research payments, 2019–2025

Across 6 payments — averaging $105,550 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$633K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$23,482
Medicare patients
69
Services billed
1,610

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$100,625
Carbidopa-LevodopaCarbidopa/Levodopa179$6,980
Droxidopa13$4,118
Selegiline Hcl22$2,803
Carbamazepine13$1,032
Gabapentin51$563
Entacapone13$531
Clonazepam27$380
Propranolol Hcl26$296
Carbidopa-Levodopa ErCarbidopa/Levodopa16$273
Primidone16$223
Venlafaxine Hcl ErVenlafaxine Hcl12$205
Donepezil Hcl29$151
Duloxetine Hcl11$145

Paid to pharmacies, not to this prescriber.

Other neurology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →